Cambridge Enterprise focuses its investments on high-impact, high-growth early-stage spin-outs and start-ups emerging from the University of Cambridge and related research institutions. Their strategy involves providing early-stage equity investment and support across diverse sectors such as life sciences, physical sciences, sustainability, healthcare, and digital health, leveraging the Cambridge ecosystem to accelerate venture development.
Portfolio
3
Fund Size
$35M
Top Stage
Series B
Last 12 Mo
1
Stage Distribution
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Sparxell | Series A | $5M | Feb 2026 |
| Carbon Re | Seed | $4.8M | Nov 2022 |
| Colorifix | Series B | $22.6M | May 2022 |
Top Co-Investors
H&M Group1 shared
Regeneration.VC1 shared
Planet A1 shared
Clean Growth Fund1 shared
UCL Technology Fund1 shared
Last updated: 1 March 2026